Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 0 | 10,091 | 0 | 406 |
| Gross Profit | N/A | N/A | 10,091 | 0 | 406 |
| Operating Expenses | 67,876 | 58,929 | 48,848 | 53,271 | 43,311 |
| Operating Income | -67,876 | -58,929 | -38,757 | -53,271 | -42,905 |
| Interest Expense | 10,686 | 10,174 | 19,269 | 30,128 | 5,014 |
| Other Income | -3,510 | 10,882 | 5,328 | 6,204 | 2,049 |
| Pre-tax Income | -82,072 | -58,221 | -52,698 | -77,195 | -45,870 |
| Income Tax | 22 | 51 | -8 | -24 | -21 |
| Net Income Continuous | -82,094 | -58,272 | -52,690 | -77,171 | -45,849 |
| Net Income | $-82,094 | $-58,272 | $-52,690 | $-77,171 | $-45,849 |
| EPS Basic Total Ops | -0.31 | -0.22 | -0.24 | -0.45 | -0.26 |
| EPS Basic Continuous Ops | -0.31 | -0.22 | -0.24 | -0.44 | -0.26 |
| EPS Diluted Total Ops | -0.31 | -0.22 | -0.24 | -0.45 | -0.26 |
| EPS Diluted Continuous Ops | -0.31 | -0.22 | -0.24 | -0.44 | -0.26 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.22 | -0.24 | -0.44 | -0.26 |
| EBITDA(a) | $-65,938 | $-57,034 | $-36,951 | $-51,496 | $-41,526 |